ABSTRACT
Antibodies are assembled by a highly orchestrated series of recombination events during B cell development. One of these events, class switch recombination, is required to produce the IgG, IgE and IgA antibody isotypes characteristic of a secondary immune response. The action of the enzyme activation induced cytidine deaminase is now known to be essential for the initiation of this recombination event. Previous studies have demonstrated that the immunoglobulin switch regions acquire distinct histone modifications prior to recombination. We now present a high resolution analysis of these histone modifications across the IgE switch region prior to the initiation of class switch recombination in primary human B cells and the human CL-01 B cell line. These data show that upon stimulation with IL-4 and an anti-CD40 antibody that mimics T cell help, the nucleosomes of the switch regions are highly modified on histone H3, accumulating acetylation marks and tri-methylation of lysine 4. Distinct peaks of modified histones are found across the switch region, most notably at the 5' splice donor site of the germline (I) exon, which also accumulates AID. These data suggest that acetylation and K4 tri-methylation of histone H3 may represent marks of recombinationally active chromatin and further implicates splicing in the regulation of AID action.
Subject(s)
B-Lymphocytes/cytology , B-Lymphocytes/metabolism , Chromatin/genetics , Immunoglobulin E/genetics , Immunoglobulin Switch Region/genetics , Adolescent , B-Lymphocytes/drug effects , CD40 Antigens/metabolism , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line , Child , Child, Preschool , Chromatin/drug effects , Chromatin Assembly and Disassembly/drug effects , Chromatin Assembly and Disassembly/genetics , Genetic Loci/drug effects , Genetic Loci/genetics , Humans , Immunoglobulin Switch Region/drug effects , Interleukin-4/pharmacology , Palatine Tonsil/immunology , Recombination, Genetic/drug effects , Recombination, Genetic/genetics , Transcription, Genetic/drug effects , Transcription, Genetic/geneticsABSTRACT
Donor-reactive memory T cells undermine the survival of transplanted organs through multiple pathways. We have previously reported that memory CD4 T cells resist treatment with anti-CD154 antibody and donor-specific transfusion (DST/MR1) and promote cardiac allograft rejection via generation of effector CD4 T cells and alloantibody. We hypothesized that the helper functions of memory CD4 T cells are independent of T-cell costimulation through CD154 but instead are regulated by alternative costimulatory pathways. This study investigated how blocking ICOS/B7RP-1 interactions affects functions of donor-reactive memory CD4 T cells. Treatment with blocking anti-ICOS mAb synergized with DST/MR1 and prolonged mouse cardiac allograft survival despite the presence of donor-reactive memory CD4 T cells. While blocking ICOS did not diminish the expansion of preexisting memory CD4 T cells or the induction of allospecific effector T cells, it did inhibit recruitment of the activated memory and effector T cells into the graft. In addition, anti-ICOS mAb treatment in combination with DST/MR1 prevented help provided by memory CD4 T cells for production of donor-specific IgG antibody. These results demonstrate the potential efficacy of ICOS blockade in sensitized transplant patients and provide the foundation for rational use of ICOS blockade in combination with other graft-prolonging strategies.
Subject(s)
Antigens, Differentiation, T-Lymphocyte/drug effects , Antigens, Differentiation, T-Lymphocyte/metabolism , CD4-Positive T-Lymphocytes/immunology , Graft Rejection/immunology , Graft Rejection/prevention & control , Heart Transplantation , Animals , Antibodies, Monoclonal/pharmacology , B7-1 Antigen/metabolism , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Carrier Proteins/drug effects , Cytoskeletal Proteins/drug effects , Dystonin , Female , Graft Rejection/pathology , Graft Survival/drug effects , Histocompatibility Antigens Class I/drug effects , Immunoglobulin Switch Region/drug effects , Immunologic Memory/drug effects , Inducible T-Cell Co-Stimulator Ligand , Inducible T-Cell Co-Stimulator Protein , Male , Mice , Mice, Inbred Strains , Minor Histocompatibility Antigens , Nerve Tissue Proteins/drug effectsABSTRACT
The CpG motif in DNA plays a critical role in immunity via modulating the Th1/Th2 balance. In B cells, CpG-containing oligodeoxynucleotides (CpG ODNs) inhibit IL-4-mediated class switch recombination (CSR) to IgG1 and IgE through inhibition of the germline transcription (GLT) of these isotypes. However, the molecular mechanism of this inhibitory effect remains elusive. We showed here that Id2 and Bcl6, both of which inhibit IgE GLT and CSR, are not involved in this inhibitory pathway. We demonstrated that there is reduced activity of NF kappa B binding to the IgE promoter and a reduction of Irf4 protein in CpG ODN-treated B cells. These data indicate the critical role of NF kappa B and Irf4 in the regulation of IgE CSR through actions downstream of CpG signaling.
Subject(s)
B-Lymphocytes/metabolism , CpG Islands , DNA-Binding Proteins/metabolism , Immunoglobulin Switch Region/physiology , NF-kappa B/metabolism , Oligonucleotides/pharmacology , Proto-Oncogene Proteins/metabolism , Repressor Proteins/metabolism , Transcription Factors/metabolism , Animals , B-Lymphocytes/drug effects , Cells, Cultured , Immunoglobulin E , Immunoglobulin Switch Region/drug effects , Inhibitor of Differentiation Protein 2 , Interleukin-4/metabolism , Mice , NF-kappa B/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-6 , Signal Transduction/drug effects , Signal Transduction/physiologyABSTRACT
The rabbit genome has 13 different Calpha genes that are expressed at different levels in mucosal tissues. To analyze the factors involved in the differential expression of these Calpha genes, we cloned and sequenced the promoters of the Ialpha regions that control the expression of sterile mRNA. We found that all Calpha genes, including Calpha3 and Calpha8, which are not expressed, and Calpha4, which is expressed at high levels, have similar nucleotide sequences in the Ialpha region, and all contain the recognition elements for TGF-beta in the promoter. B lymphocytes from popliteal lymph nodes or Peyer's patch activated in vitro could be induced by TGF-beta to express sterile IgA transcripts of all IgA isotypes, except Calpha2, Calpha3, and Calpha8. Many single B lymphocytes transcribed sterile mRNA of more than one IgA isotype, which demonstrates that transcription of sterile mRNA alone does not regulate the IgA isotype switch. The addition of IL-2 led to the expression of transcripts of mature IgA of all isotypes, except Calpha2, Calpha3, and Calpha8. The predominantly expressed isotype in these experiments was Calpha4. With the use of an IgA4-specific mAb we found that IgA4+ plasma cells are unevenly distributed throughout the small intestine such that many of the IgA+ plasma cells in the duodenum-jejunum produced IgA4, whereas in the lower part of the ileum IgA4-producing cells were almost absent. Because the microbial flora varies throughout the intestine, we suggest that the microbial flora creates different local environments and thus affects either isotype switching or homing of IgA-expressing cells.
Subject(s)
B-Lymphocytes/metabolism , Gene Expression Regulation/immunology , Genes, Immunoglobulin , Immunoglobulin A/genetics , Immunoglobulin Isotypes/genetics , Interleukin-2/physiology , Transforming Growth Factor beta/physiology , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Base Sequence , DNA Primers/immunology , Fluorescent Antibody Technique, Direct , Gene Expression Regulation/drug effects , Genes, Immunoglobulin/drug effects , Immunoglobulin A/biosynthesis , Immunoglobulin Constant Regions/genetics , Immunoglobulin Isotypes/biosynthesis , Immunoglobulin Switch Region/drug effects , Immunoglobulin Switch Region/genetics , Intestine, Small/chemistry , Intestine, Small/cytology , Intestine, Small/immunology , Molecular Sequence Data , Plasma Cells/chemistry , Plasma Cells/cytology , Promoter Regions, Genetic/immunology , Rabbits , Staining and LabelingABSTRACT
Previous studies suggest that heavy chain isotype switch (S) recombination is directed by cytokine-induced transcription of the unrearranged CH gene before recombination. In studies aimed at identifying other signaling pathways that promote switching, we discovered that inhibitors of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) increase LPS-induced switching to IgA in the B cell lymphoma 1.29 mu and to IgG1 in LPS + IL-4-treated splenic B cells. PARP, which binds to and is activated by DNA strand breaks, catalyzes the removal of ADP-ribose from NAD+ and poly(ADP-ribosylation) of chromatin-associated acceptor proteins. This enzyme is believed to function in cellular processes involving DNA strand breaks as well as in modulating chromatin structure. In 1.29 mu cells, PARP inhibitors increase IgA switching by day 2 and cause a fivefold increase in switching on day 3 as assayed by immunofluorescence microscopy. In spleen B cells, the PARP inhibitor nicotinamide increases IgG1 switching by about twofold. Nicotinamide also causes a reduced intensity of hybridization of C mu- and C alpha-specific probes to genomic DNA fragments containing the expressed VDJ-C mu and the unrearranged S alpha-C alpha segments, respectively, in 1.29 mu cells, indicating that PARP inhibition increases rearrangement of these fragments. Induction of switching by PARP inhibitors is not mimicked by treatment with cAMP analogues or reduced by inhibitors of protein kinase A. Induction of switching by PARP inhibitors does not appear to involve increased levels of transcription of the unrearranged C alpha gene.
Subject(s)
Immunoglobulin Switch Region/drug effects , Poly(ADP-ribose) Polymerase Inhibitors , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/enzymology , B-Lymphocytes/immunology , Cell Line , Chromosome Mapping , Cyclic AMP/pharmacology , Gene Rearrangement, B-Lymphocyte , Immunoglobulin A/biosynthesis , Immunoglobulin A/genetics , In Vitro Techniques , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred BALB C , Niacinamide/pharmacology , Transforming Growth Factor beta/pharmacology , Xanthines/pharmacologyABSTRACT
The immunosuppressive activity and comparative efficacy of rapamycin (RAPA), FK 506 and cyclosporine A (CsA) were investigated in rats following immunization with either xenogeneic sheep red blood cells (SRBC) or allogeneic blood transfusion. RAPA formulated in a polyethylene glycol vehicle, and at a dose of 1.5 mg.kg-1 i.p., was relatively ineffective when compared with FK 506 (1 mg.kg-1) or CsA (15 mg.kg-1) in suppressing antibody production to SRBC. Like FK 506 and CsA however, RAPA proved highly effective in suppressing both the B lymphocytosis and the increase in circulating major histocompatibility complex class II+ cells observed following immunization. All three immunosuppressants caused thymic medullary atrophy, with evidence of epithelial cell damage and increased macrophage phagocytic activity. Administered i.m. (3 mg.kg-1 in olive oil), RAPA was also highly effective in suppressing 1 degree alloantibody responses to MHC class I antigens following blood transfusion. Unlike FK 506 and CsA however, a short (14-day) course of RAPA following 1 degree immunization (transfusion) did no suppress 2 degree alloantibody responses elicited 6 weeks later. Moreover, RAPA did not prevent immunoglobulin isotype switching as observed with FK 506 and CsA. This may reflect the distinct mechanisms of action of RAPA and the latter two agents on T-cell activation/proliferation. Further comparative and combination studies of RAPA with in particular, CsA, are required to further explore to potential of RAPA as an immunotherapeutic agent.
Subject(s)
Cyclosporine/pharmacology , Immune System/drug effects , Immunosuppressive Agents/pharmacology , Polyenes/pharmacology , Tacrolimus/pharmacology , Animals , Antibody Formation/drug effects , Erythrocytes/immunology , Immunoglobulin Isotypes/drug effects , Immunoglobulin Isotypes/genetics , Immunoglobulin Switch Region/drug effects , Lymphocyte Subsets/drug effects , Lymphocyte Subsets/immunology , Male , Rats , Rats, Sprague-Dawley , Sheep , Sirolimus , Thymus Gland/drug effects , Thymus Gland/pathologyABSTRACT
CH12.LX B cells have been used as a lymphoma model of MHC restricted, antigen-dependent B cell differentiation. These B cells express surface IgM and secrete IgM. Most recently we have demonstrated that CH12.LX is a model of cytokine driven IgA differentiation. Recently, transforming growth factor beta (TGF-beta) has been shown to be a probable switch factor for IgA in LPS-stimulated mouse lymphocytes, therefore we chose CH12.LX B cells to study the effect of IL-4, TGF-beta and LPS in IgA isotype switching. Adding TGF-beta to the monoclonal cell line CH12.LX results in induction of mIgA expression but no enhancement of IgA secretion similar to the effect of IL-4. The addition of LPS serves as a non-specific stimulus to enhance the secretion of the expressed immunoglobulin, but has no IgA specific activity of its own. IL-4 and TGF-beta together are synergistic for mIgA expression. Pretreatment studies show that TGF-beta added after IL-4 is the same as TGF-beta alone whereas the converse is the same as adding both cytokines together. TGF-beta acts by increasing the steady state levels of alpha message, whereas northern analysis indicates that IL-4 does not induce alpha message the way TGF-beta does. These data confirm that TGF-beta by itself is an isotype switch factor for IgA. In addition, IL-4 and TGF-beta cause mIgA expression through different mechanisms. CH12.LX B cells serve as a valuable model to study the role of multiple signals required for mIgA expression and IgA secretion.
Subject(s)
Immunoglobulin A/metabolism , Interleukin-4/pharmacology , Lipopolysaccharides/immunology , Transforming Growth Factor beta/pharmacology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Differentiation/drug effects , Cell Line , Drug Synergism , Immunoglobulin A/genetics , Immunoglobulin Switch Region/drug effects , Interleukin-4/administration & dosage , Mice , Transcription, Genetic/drug effects , Transforming Growth Factor beta/administration & dosageABSTRACT
We have characterized extrachromosomal circular DNAs from adult mouse spleen cells that were induced to switch to immunoglobulin A (IgA) with bacterial lipopolysaccharide (LPS) and transforming growth factor beta (TGF-beta), and identified breakpoints of S mu/S gamma 3, S mu/S gamma 2, S mu/S alpha, S gamma 3/S alpha, and S gamma 2/S alpha recombinants. The S mu recombination donor sites clustered in the 3' half of the S mu region, while the S alpha recombination acceptor sites clustered in the 5' half of the S alpha region. In addition, donor and acceptor sites of S gamma regions also clustered in the 3' and 5' parts, respectively. These site preferences are in sharp contrast to the dispersed distribution of S mu/S gamma 1 breakpoints within both S mu and S gamma 1 regions upon IgG1 switch induced by LPS and interleukin 4. Our results support the hypotheses that TGF-beta increases the frequency of switch recombination events to IgA and that the switch recombination to IgA often proceeds by successive recombination of S mu/S gamma and S gamma/S alpha.
Subject(s)
Genes, Switch , Immunoglobulin G/genetics , Immunoglobulin Switch Region , Recombination, Genetic , Transforming Growth Factor beta/pharmacology , Animals , Base Sequence , Cloning, Molecular , DNA, Circular/genetics , Female , Gene Library , Genes, Switch/drug effects , Immunoglobulin Switch Region/drug effects , Interleukin-4/pharmacology , Lipopolysaccharides , Mice , Mice, Inbred BALB C , Models, Genetic , Molecular Sequence Data , Oligodeoxyribonucleotides , Plasmids , Recombination, Genetic/drug effects , Restriction Mapping , Spleen/immunologyABSTRACT
Transforming growth factor beta (TGF-beta) and IL-5 have been shown to augment IgA production by LPS-stimulated murine B cells. We investigated the effect of TGF-beta on the expression of surface Ig-isotype and IL-5 receptor on LPS-stimulated B cells. TGF-beta increased the proportion of both surface IgA-positive (sIgA+) B cells and sIgG2b+ B cells and enhanced IgA and IgG2b production by LPS-stimulated B cells. TGF-beta synergized with IL-5 only for IgA production of the seven Ig-isotypes and in combination with IL-5 caused a significant increase in the proportion of sIgA+ B cells up to 17.4%. In contrast, IL-5 decreased the proportion of sIgG2b+ B cells and sIgG3+ B cells and inhibited the production of IgG2b and IgG3 by LPS-stimulated B cells. About 50% of sIgA+ cells induced by TGF-beta expressed IL-5 receptor. They secreted peak levels of IgA and seemed to maintain long viability in the presence of IL-5; whereas TGF-beta had the opposite effects on sIgA+ B cells and down-regulated the IL-5 receptor expression. These results indicate that TGF-beta increases the number of sIgA(+)- and IL-5 receptor-positive B cells which respond to IL-5 giving rise to IgA-secreting cells and also support the notions that TGF-beta preferentially induces switching to sIgA+ B cells and IL-5 induces the maturation of postswitch sIgA+ B cells into IgA-secreting cells in a stepwise fashion.
Subject(s)
B-Lymphocytes/drug effects , Immunoglobulin A/biosynthesis , Interleukin-5/pharmacology , Receptors, Interleukin , Transforming Growth Factor beta/pharmacology , Animals , Antibodies/immunology , B-Lymphocytes/immunology , B-Lymphocytes/ultrastructure , Cell Membrane/drug effects , Cell Separation , Cells, Cultured/drug effects , Dose-Response Relationship, Drug , Flow Cytometry , Immunoglobulin A, Secretory/analysis , Immunoglobulin Isotypes/analysis , Immunoglobulin Switch Region/drug effects , Lipopolysaccharides , Lymphocyte Activation/drug effects , Mice , Mice, Inbred C57BL , Receptors, Immunologic/analysis , Receptors, Immunologic/drug effects , Receptors, Interleukin-5 , Spleen/cytologyABSTRACT
Immunoglobulin (Ig) class switching appears to be preceded by induction of germ-line transcripts. In this report, we demonstrate that transforming growth factor beta (TGF-beta) induces germ-line transcripts of both the IgA subclasses (IgA1 and IgA2) in Branhamella catarrhalis (BC)-activated human spleen B cells. Two germ-line bands, one of approximately 1.85 kb and the other of approximately 1.6 kb, could be seen in cultures treated with TGF-beta. The approximately 1.85 kb band contains mRNA for a germ-line transcript of the membrane form. This band co-migrates with the productive secreted form of alpha mRNA. The other, shorter form of approximately 1.6 kb did not correlate in size with any known form of productive alpha mRNA and contained the secreted form of germ-line alpha mRNA. The induction of alpha germ-line transcripts was accompanied by a concomitant suppression of mu and gamma mRNA. We have also identified the location of a putative I alpha sequence (designated according to the generally accepted nomenclature) within approximately 0.5 kb upstream to the switch alpha (S alpha) region. The relative proportions of IgA-subclass-specific mRNA in TGF-beta-stimulated spleen B cells are concordant with the distribution pattern seen in pokeweed mitogen (PWM)-stimulated spleen mononuclear cells (MNC), which was 89 and 11% for the IgA1 and the IgA2 mRNA respectively. These results suggest a role of TGF-beta in regulating IgA class switching in human B lymphocytes.
Subject(s)
B-Lymphocytes/drug effects , Immunoglobulin A/genetics , Transcription, Genetic/drug effects , Transforming Growth Factor beta/pharmacology , B-Lymphocytes/immunology , Cell Line , Humans , Immunoglobulin A/classification , Immunoglobulin Switch Region/drug effects , In Vitro Techniques , Moraxella catarrhalis/immunology , RNA, Messenger/geneticsABSTRACT
Treatment of splenic B lymphocytes and certain B-lineage cell lines with the mitogen lipopolysaccharide (LPS) and the lymphokine interleukin-4 (IL-4) induces expression of germ line immunoglobulin C epsilon transcripts and class switching to the C epsilon gene. We show that LPS-plus-IL-4 induction of germ line epsilon transcripts (termed I epsilon transcripts) occurs at the transcriptional level in an Abelson murine leukemia virus-transformed pre-B-cell line. A 1.1-kb region of DNA surrounding the I epsilon promoter endows inducible transcription to a heterologous reporter gene stably transfected into these cells; such inducible expression depends on combined treatment with LPS and IL-4. Analyses of constructs transiently introduced into a B-cell lymphoma line demonstrated that LPS-plus-IL-4-inducible expression can be conferred by a 179-bp segment of DNA spanning the I epsilon transcriptional initiation site. Mutational analyses demonstrated that this expression depended on DNA sequences within a conserved region directly upstream from the I epsilon transcriptional initiation region. One nuclear protein that is constitutively expressed in normal B cells binds to the downstream end of the conserved sequence; its binding specificity correlates with the functional effect of several mutations. Two additional proteins, which are induced by IL-4 treatment of splenic B cells, bind to the transcription initiation sites of I epsilon. These proteins are indistinguishable in binding assays from proteins previously shown to bind an enhancer region of the class II major histocompatibility complex gene A alpha.
Subject(s)
Immunoglobulin Switch Region/drug effects , Immunoglobulin epsilon-Chains/genetics , Interleukin-4/pharmacology , Lipopolysaccharides , Promoter Regions, Genetic , Transcription, Genetic , Abelson murine leukemia virus/genetics , Animals , Base Sequence , Cell Line , Cell Line, Transformed , Immunoglobulin Constant Regions/genetics , Lymphoma, B-Cell , Mice , Molecular Sequence Data , Oligonucleotides , Promoter Regions, Genetic/drug effects , TransfectionSubject(s)
Immunoglobulin A/biosynthesis , Immunoglobulin Switch Region , Transforming Growth Factor beta/immunology , Animals , Immunoglobulin A/genetics , Immunoglobulin Switch Region/drug effects , Models, Biological , Transforming Growth Factor beta/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/immunologySubject(s)
Cholera Toxin/pharmacology , Immunoglobulin Isotypes/biosynthesis , Adjuvants, Immunologic/administration & dosage , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Cell Differentiation/drug effects , Cholera Toxin/administration & dosage , Drug Synergism , Immunoglobulin Isotypes/genetics , Immunoglobulin Switch Region/drug effects , Interleukin-4/administration & dosageABSTRACT
Interleukin 4 (IL-4) can induce the expression of IgG1 in sIgG- murine B cells stimulated with mitogens or through a cognate interaction with T helper (Th) cells. We have investigated the molecular basis for the IL-4-induced switch to IgG1 in lipopolysaccharide (LPS)-stimulated murine B cells and have previously shown that IL-4 induces transcription of the gamma 1 switch region before switch recombination. We now demonstrate that IL-4 induces a DNase I hypersensitive site at the 5' end of the gamma 1 switch region in resting B cells. LPS is not required, but it enhances induction. Hence, the interaction of IL-4 with its receptor results in increased accessibility of the gamma 1 switch region. The more open chromatin structure and increased transcriptional activity may be important in the selection of this region for switch recombination.
Subject(s)
B-Lymphocytes/ultrastructure , Chromatin/ultrastructure , Immunoglobulin Switch Region/genetics , Interleukin-4/physiology , Animals , B-Lymphocytes/drug effects , Blotting, Southern , Cells, Cultured , Chromatin/drug effects , Deoxyribonuclease I/metabolism , Female , Gene Rearrangement, B-Lymphocyte , Immunoglobulin Switch Region/drug effects , Lipopolysaccharides , Mice , Mice, Inbred BALB C , Transcription, Genetic/drug effectsSubject(s)
Gene Expression Regulation , Genes, MHC Class II , Lymphokines/genetics , T-Lymphocytes/metabolism , Antigens, Differentiation, T-Lymphocyte/immunology , B-Lymphocytes/cytology , B-Lymphocytes/drug effects , Cloning, Molecular , Humans , Immunoglobulin Switch Region/drug effects , Lymphocyte Activation , Lymphokines/metabolism , Lymphokines/physiology , Multigene Family , Phenotype , T-Lymphocytes/classification , T-Lymphocytes/immunologyABSTRACT
Interleukin 4 (IL4) directs class switch recombination to the gamma 1 switch region (s gamma 1) in mitogen-activated murine B lymphocytes. The finding that transcription of the unrearranged s gamma 1 and its 5' flanking region is induced by IL4 prior to switch recombination had argued for the idea that IL4 promotes s mu/s gamma 1 switch recombination by selectively inducing accessibility of the gamma 1 switch region for a general switch recombinase. Here further evidence for this model is provided by showing that within less than 6 h IL4 induces a DNase I hypersensitive (HS) site 5' adjacent to the s gamma 1 region in activated murine B cells. This change in chromatin structure most likely reflects the IL4-responsive binding of regulatory proteins within or in the vicinity of the HS site. The result provides a candidate sequence for an IL4-dependent enhancer/promoter of transcription of s gamma 1.
Subject(s)
Immunoglobulin Switch Region/genetics , Interleukin-4/pharmacology , Animals , B-Lymphocytes/immunology , Deoxyribonuclease I , Immunoglobulin Switch Region/drug effects , Immunoglobulin gamma-Chains/genetics , Mice , Mice, Inbred BALB C , Recombination, GeneticABSTRACT
The induction of immunoglobulin heavy chain classes switch from IgM to IgG was demonstrated in vitro in cells of RPMI-6410t line. The IgG+-sublines, formed as a result of the switch are characterized by instability of IgG synthesis. After removal of the inductor from the growth environment, IgG+ cells gradually reduce the level of secreted IgG. Such a transition to the functional rest state is likely to be connected with the convertible Ig-gene activity suppression in IgG+ cells, since after their activation by LPS IgG-secretion is partly or completely restored. The IgG+-sublines obtained may serve a convenient model for investigating the Ig-gene expression regulation in differentiated human B-cells.